177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation

被引：19
|
作者：
Assadi, Majid [1 ]
Pirayesh, Elahe [2 ]
Rekabpour, Seyed Javad [3 ]
Zohrabi, Farshad [4 ]
Jafari, Esmail [1 ]
Nabipour, Iraj [5 ]
Esmaili, Abdolhamid [6 ]
Amini, Abdullatif [7 ]
Ahmadzadehfar, Hojjat [8 ]
机构：
[1] Bushehr Univ Med Sci, Bushehr Med Univ Hosp, Persian Gulf Nucl Med Res Ctr, Dept Mol Imaging & Radionuclide Therapy,Fac Med, Bushehr, Iran
[2] Shahid Beheshti Univ Med Sci, Shohada & Tajrish Med Ctr, Dept Nucl Med, Tehran, Iran
[3] Bushehr Med Univ Hosp, Dept Oncol, Bushehr, Iran
[4] Bushehr Med Univ Hosp, Dept Urol, Bushehr, Iran
[5] Bushehr Med Univ Hosp, Dept Internal Med, Div Endocrinol, Bushehr, Iran
[6] Bushehr Med Univ Hosp, Dept Pathol, Bushehr, Iran
[7] Bushehr Univ Med Sci, Dept Cardiol, Bushehr Heart Med Ctr, Bushehr, Iran
[8] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany
来源：
CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 12期
关键词：
prostate cancer; neuroendocrine differentiation; Lu-177-PSMA; Lu-177-DOTATATE; GA-68-PSMA; MEDICINE;
D O I：
10.1097/RLU.0000000000002824
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
We presented a promising result of radionuclide therapy using Lu-177-PSMA and Lu-177-DOTATATE in a patient with prostatic adenocarcinoma and neuroendocrine differentiation. Functional imaging of somatostatin receptors in patients with metastatic castration-resistant prostate cancer may pave the way toward implementation of novel radionuclide targets for the treatment of this aggressive subtype of prostate cancer.
引用
收藏
页码：978 / 980
页数：3
相关论文
共 50 条
  • [41] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Mair, Christian
    Warwitz, Boris
    Fink, Katharina
    Scarpa, Lorenza
    Nilica, Bernhard
    Maffey-Steffan, Johanna
    Buxbaum, Sabine
    Virgolini, Irene J.
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (07) : 499 - 502
  • [42] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Christian Mair
    Boris Warwitz
    Katharina Fink
    Lorenza Scarpa
    Bernhard Nilica
    Johanna Maffey-Steffan
    Sabine Buxbaum
    Irene J. Virgolini
    Annals of Nuclear Medicine, 2018, 32 : 499 - 502
  • [43] 177Lu-PSMA in Metastatic Castration Resistant Prostate Cancer: Preliminary Analisys of Brazilian Multicentric Study
    Etchebehere, E.
    Heringer, V.
    Correia, J.
    Marin, J.
    Mosci, C.
    Anjos, D.
    Filho, P.
    Gomes, G.
    Villela-Pedras, F.
    Ribeiro, F.
    Buchpiguel, C.
    Bastos, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S674 - S674
  • [44] Administration of 177Lu-PSMA-617 as Compared to 177Lu-Dotatate
    Patel, P.
    McCall, K.
    MEDICAL PHYSICS, 2022, 49 (06) : E811 - E812
  • [45] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Jianpeng Cao
    Yue Chen
    Mei Hu
    Wei Zhang
    Annals of Nuclear Medicine, 2021, 35 : 861 - 870
  • [46] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Cao, Jianpeng
    Chen, Yue
    Hu, Mei
    Zhang, Wei
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (08) : 861 - 870
  • [47] 177Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysis
    Sadaghiani, Mohammad S.
    Sheikhbahaei, Sara
    Werner, Rudolf A.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    Solnes, Lilja B.
    Rowe, Steven P.
    PROSTATE, 2022, 82 (07): : 826 - 835
  • [48] First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Kao, Yung Hsiang
    Falzone, Nadia
    Pearson, Michael
    Sivaratnam, Dinesh
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2024, 52 (03)
  • [49] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [50] Radioligand Therapy with 177Lu-PSMA in Metastatic Castration Resistant Prostate Cancer Patients: First case series in Iran
    Aryana, K.
    Moghadam, S. Zarehparvar
    Divband, G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S649 - S650
12345